![Paul Secrist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Secrist
Keine laufenden Positionen mehr
Karriereverlauf von Paul Secrist
Ehemalige bekannte Positionen von Paul Secrist
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYTEIR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 | 01.04.2023 |
LifeMine Therapeutics, Inc.
![]() LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | 01.06.2020 |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | 01.09.2011 | 01.12.2017 |
Technik-/Wissenschafts-/F&E-Leiter | 01.09.2011 | 01.12.2017 |
Ausbildung von Paul Secrist
Wartburg College | Undergraduate Degree |
Mayo Clinic College of Medicine & Science | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Cyteir Therapeutics, Inc.
![]() Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
LifeMine Therapeutics, Inc.
![]() LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
- Börse
- Insiders
- Paul Secrist
- Erfahrung